These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26721730)

  • 1. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    Kuo YC; Cheng SJ
    Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
    Kuo YC; Wang IH
    J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
    Kuo YC; Shih-Huang CY
    J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
    Kuo YC; Liang CT
    Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
    Kuo YC; Lee CH
    Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-targeted, drug-loaded solid lipid nanoparticles against glioblastoma cells in culture.
    Ak G; Ünal A; Karakayalı T; Özel B; Selvi Günel N; Hamarat Şanlıer Ş
    Colloids Surf B Biointerfaces; 2021 Oct; 206():111946. PubMed ID: 34216850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
    Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
    Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
    Kuo YC; Lee CH
    J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
    Kuo YC; Ko HF
    Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
    Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y
    Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
    Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
    Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.
    Kuo YC; Chao IW
    Biotechnol Prog; 2016 Mar; 32(2):480-90. PubMed ID: 26701338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
    Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
    Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
    Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
    Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.